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CHAPTER I
INTRODUCTION AND REVIEW OF THE LITERATURE
Introduction
South American Camelid .(SAC's)
The genus of Came/us has evolved and speciated into. Lammi and Came/iJli in
North America during the Eocene epoch some 40-50 million years ago (Fowler, 1998)
During the Pleistocene epoch, the LamiJ1j has further evolved into the modern day South
American camelids (SAC's) and migrated throughout the western hemisphere How-
ever, they became extinct in the later part of the century on the North American
continent (Fowler, 1998) The Camelini, "old world camelids" migrated to Eurasia over
the Bering land bridge during the Pleistocene epoch, where they later became
domesticated (Fowler, 1998). The (SAC's) were domesticated around 4000 BC, and
became a main stay of the Inca empire, providing food, clothing, and transportation
(Fowler, 1998, Hoffman, 1996)
During the nineteenth century, SAC's were exported to other countries of the
world as zoo animals. This exportation ended at the turn of the century when all of the
Andean countries including Peru and Bolivia with portions of Argentina, Chile,
Colombia, and Ecuador prohibited the export of these animals, In the 1980's, the ban on
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exportation was lifted for alpacas (iAnw pacos) and llamas (Lama glama) , by the
countries containing the Andes mountains including Peru, and Bolivia Presently,
imports of SAC's into the U S.A are limited by public health concerns, such as the
spread of Foot and Mouth Disease (Fowler, 1998). The number of Llamas (Lama
glama) in North America is currently around 100,000 with approximately 10,000
Alpacas(Lama pacos), and smaller numbers of vicuna(Vicugna vicugna) and guanaco
(hmw guonicoe) (personal communication). There are about 1500 Llamas raised by at
least 50 farms in Oklahoma (Oklahoma Breeders Association, 1998).
The General Biology of SAC's
Llamas are one of the four species known as New world camelids which inhabit
the Andean countries, the other being the alpaca, the guanaco, and the vicuna. The four
members of the genus Llama are so closely related, that they all produce fertile hybrids
when crossbred. Llamas and alpacas exist only as domestic species. Vicunas and
guanacos are the only two species that can still be found in the wild (Fowler, 1998) The
Llama was bred specifically to produce a large. strong animal for packing function, while
the alpaca was bred to accentuate its natural finer wool (Hoffman, 1996).
Obviously modern transportation has reduced the importance of the llama as
beast of burden. Primary emphasis is now being placed on this animal primarily as a
source of food and secondarily as fiber (Fowler, 1998).
The SACs including Llamas and alpacas are induced ovulators, stimulated by
copulation with their respective males. Llamas have an 11 month gestation period
(Fowler, 1998).
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The Gastrointestinal System; its Anatomy and Physiology
SAC's including llamas are modified herbivorous ruminants, and ungulates with
some major anatomical and physiological differences. The SAC's having evolved during
the arid Pleistocene epoch have developed specific adaptations for dealing with
dehydration and extremes in temperature.
Ruminants have a four chambered stomach (Figure 1); the rumen, the first
chamber receives food when first ingested.
Reticulum
Figure 1. Anatomy of the Ruminant Stomach (after Dice,
1987)
The reticulum which is closely associated in form and function with the rumen, has been
combined the two chambers functionally into the rumenorecticulum by many researchers.
The symbiotic flora of the ruminoreticuJum ferments normally indigestible plant material.
The rumen contains four distinct layers of stratification; the gas layer, the fibrous mat
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layer, the liquid layer and fine particulate layer. Volatile fatty acids produced by the flora
accumulate into the gas layer, are absorbed by the wa!ls of the rumen and eructated to be
absorbed through the lungs The fibrous material from this stomach is regurgitated and
chewed as a cud by the ruminant when resting to reduce the size of the particles
providing a larger surface area for the rumen flora to digest. The liquid and particulate
layers provide a media for the flora to be biologically functional. The fine particulate
material is then moved into the omasum, the third compartment Digestion continues in
this companmenr through grinding of plant material into still finer panicles while
squeezing the ingesta to remove excess water In the abomasum, the glandular stomach
of the ruminant completes digestion through acidification and enzymatic action. The
ingested food then passes on to the small intestine, for absorption of nutrients into
systemic circulation. The total length of both small and large intestine is approximately
50 m in ruminants (Dice, 1987)
The unique characteristics of the SAC's stomach include ill defined pillars and
columns SAC's have a three chambered stomach: C-1, C-2, and C-3 (Figure 2).
Llamas lack the stratification of ingesta, analogous to that of the ruminants and do not
accumulate gas Volatile fatty acids are absorbed rapidly from the C-I stomach at a rate
2-3 times greater than sheep These animals can recycle the urea from the blood stream
through the stomach, allowing symbiotic flora to utilize it as a nitrogen source for
protein production. This enables SAC's to extract more protein and energy from poor
quality forage than their cousins, the ruminants. The ingesta of C-3 is relatively dry
compared to that of a ruminant, due to the absorption of the water in the proximal 4/5 of
the stomach. The terminal 1/5 of the C-3 stomach contains the gastric glands. The total
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length of SAC's small intestine is 11.5-12.0 m with I, 9.5-lO.0, and 1.0 m in lengths ot
duodenum, jejunum and ileum respectively. The large colon is 7.S m with the caecum 10
em in length and the small colon of6.0 m in length (Fowler, 1998)
Figure 2. Anatomy of the South American Camelid Stomach
Gastrointestinal Parasitism in Llamas
All animals, including llamas, are host to a number of external and internal
parasites (Fowler, J998; Johnson, 1994). Many llama owners feel that these animals are
parasite free due to the fact that these animals defecate on dung piles rather than over the
entire pasture like ruminants (Johnson, 1994). Most of the published work on the
incidence of parasitism are found in articles from South American countries, with limited
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work having been done in North America. There is accumulating evidence to indicate
that gastrointestinal parasites are significant disease producers in llamas. Studies
conducted in South American countries have demonstrated the presence of Tricho-
strongyloidea, Nematodirus, and Trichuroidea (T";chuns. and Capillaria) eggs in llamas
fecal materials Similar studies conducted in Oregon have confirmed these findings.
Trichostrongyle like eggs are produced by Haemonchus, Osterlngia, ihchoslrongylus,
Coopena, and Strongyles (Bunostomum, and Oesophagostomum), all of which are
reponed to occur in llamas as well as cattle, sheep, goat, and some wild ruminants in
North America Additional evidence indicates the presence of gastrointestinal
Trichostrongylidae including Camelstrongylus, Spiclilopteragia, Lamenema, and
CraphinemQ (Chenney, 1989)
The clinical signs of gastrointestinal parasitism in llamas are very similar to those
of parasitized cattle and sheep The parasitized llamas do not grow or mature as rapidly
as nonparasitized animals Oven clinical signs seen in llamas with heavy gas~rointestina'
parasites infestation are diarrhea, dehydration, emaciation, hypoproteinemia. and anemia
Most animals, however, will only show only sub-clinical effects of parasitism; depressed
growth rate, poor feed conversion, and depressed milk production (Rickard, 1991).
Any condition that will reduce the animal's natural health including, stress,
certain vaccinations, birthing, inadequate nutrition, vitamin deficiencies and genetic
predisposition for infection will break down the animals natural resistance to parasites.
Extremely large parasite challenges can break down and overwhelm the natural
resistance factors and cause clinical disease in llamas (Lapage, 1962)
-
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Parasitism and the Need for Chemical Control of Parasites
In the wild populations of mammals, exposure to internal parasites was naturally
kept to a minimum through herd movements (Schmidt, 1981). Additionally, through
continuous low levels of parasite infestation, animals were able to mount an Immune
response to these parasites keeping infection at a low level. Through domestication of
ungulates, man has placed restrictions on the free movement of these animals, disrupting
the balance of natural controls that evolved over a long period of time (Cheng, 1986)
Problems presented in the control of internal parasites include exquisite
adaptation to the animals they infect Parasitic helminths generally elicit a very weak
initial immune responses from the host with gradually increasing resistance to infection
after 4-6 months of exposure and resistance can be lost again in as little as 4 weeks
(Cheng, 1986), Another problem in control of intestinal parasites involves their eggs that
may survive harsh environmental conditions for extended periods of time and retain their
viability (Schmidt, 1981),
Chemical control does not totally eliminate helminth infestation: it only keeps the
numbers of parasites to a level that the animal can reasonably tolerate, Long term usage
must be balanced with the disadvantages of selecting for drug resistance in parasites
being controlled, as has seen in sheep (Roberson, )988) Older anthelmintic compounds,
including cupric sulfate, arsenic compounds and alkaloids such as nicotine, were used




Chemical Control oflnternal Parasites in SAC's
The goal for controlling internal parasites by the use of chemical compounds is to
eliminate the parasites while not causing harm to the host species. The classes of
compounds currently used in SAC's include drugs and toxins that interfere with the
parasites neuromuscular junctional transmission, energy metabolism, and transport of
energy containing molecules.
Phenothiazine, can be classified as a toxin. It was first synthesized in 1885 and
identified as an anthelmintic in the 1930s. ]t was extensively used as an anthelmintic
until the 1960s as the primary parasitic control method in ruminant livestock In the
1960's, it was discovered that parasites had developed resistance to this drug. A side
effect of phenothiazine is that it caused the urine and milk to be pink in color for several
days after administration Animals would become stained by the urine on the wool and
skin which reduced the value of each of those products. Phenothiazine is currently used
at low levels as a feed additive for continuous parasite control (Roberson, 1988).
Other drugs with a wider therapeutic index were discovered and developed for
the livestock industry. Praziquantel, a diethylenediamine causes hyperpolarization of the
muscle membranes of the cestode parasite resulting in paralysis and death PraziC]uantel
had no effect upon nematodes (Barragry, 1994). An imidazole (Levamisole) were tirst
marketed in 1965, pyridines (methyluridine) and tetrahydropyrimidines (pyrantel) were
marketed in 1966 (Barragry, 1994) lmidazoles and pyridines act by binding irreversibly
with acetylcholine (Ach) receptors They block conduction of nerve impulses across the
neuromuscular synapses paralyzmg the parasites. (Roberson, 1988; Barragry, 1994).
=
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Ivermectin (Ivomec), an avermectin introduced in ]981, increases the release of
gamma-aminobutyric acid (GABA) from the synaptic nerve endings. This hyperpolarizes
the normal resting potential of post-synaptic nerve cells, inhibiting normal nerve
transmission and causing a flaccid paralysis of muscles of the nematodes expelling them
from the host (Roberson, 1988; Barragry, 1994).
A third group of anthelmintic drugs includes, benzimidazoles, substituted phenols
and salicylanilides that interfere with energy metabolism and/or the transport of energy
containing molecules.
The salicylanilides (c1ioxanide) and substituted phenols (c1orsulon) uncouple the
electron transport system of cestodes and trematodes respectively, preventing the
oxidative phosphorlization of high energy molecules through interruption of the Krebs
cycle reactions. These particular classes of drugs act better on cestodes and trematodes
than nematodes possibly due to poor uptake of the drugs by the nematodes (Roberson,
1988, Barragry, 1994)
Benzimidazoles as Anthelmintics
Benzimidazoles are a class of drugs that fit the requirements for low toxicity, a
high degree of efficacy, numerous efficacious analogues and have the ability to vary
routes of administration for treatments. Thiabendazole, the parent compound of this
group, was discovered, developed, and then licensed for use in the 1961. Currently
benzimidazoles are utilized world wide on humans, cattle, sheep, goats, pigs, horses,
birds, and exotic wild animals. Since the development of thiabendazole, several hundred
compounds have been synthesized, based on the core structure of the compound. Of all
10
the benzimidazole analogues. ten different drugs including albendazole, cambendazole,
fenbendazole, flubendazole. mebendazole. oxfendazole, oxibendazole, parbendaxole,
thiabendazole, and thiophanate have been approved for use as anthelmintics.(Roberson,
1988)
The chemistry of the benzimidazoles is based upon substitutions to the 1,2-
diaminobenzene ring system with substitutions occurring in the number 2 and 5 nng
positions. Thiabendazole is being phased out of human medicine due to its relativity high
toxic effects. At the same time, other members of this group are widely used against a
variety of gastrointestinal helminths (Roberson, 1988, Mckellar, 1990, DeSilva, 1997;
Barragry, 1994).
With the exception of thiabendazole, albendazole, and oxfendazole, all other
members of this compound group exhibited limited absorption from the gastrointestinal
tract due to their limited solubility Thiabendazole, flubendazole and mebendazole are
rapidly absorbed, with peak plasma concentrations occurring within 2-7 hrs of admini-
stration showing variation dependent upon the species of animals treated. Albendazole,
fenbendazole, oxibendazole, parbendaxole, and thiophanate reach peak plasma
concentrations in 6-30 hrs after administration, with concentrations never more than 1%
of the administered dose (Roberson, 1988). Albendazole, cambendazole, fenbendazole,
fJubendazole, mebendazole, oxfcndazole, oxibendazole, parbendaxole, thiabendazole and
thiophanate are insoluble or only slightly soluble in water. AJbendazole, cambendazole,
oxfendazole. and parbendaxole are soluble in alcohol. Thiabendazole is only slightly
soluble in alcohol. Flubendazole, and mebendazole are soluble in formic acid
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Fenbendazole is soluble in dimethylsulfoxide. Thiophanate is soluble in cyc1ohexanone
(Roberson, 1988)
Absorption of benzimidazoles from the gastrointestinal tract is greater in
monogastric than in the ruminant animals Many benzimidazoJes are poorly absorbed
and excreted unchanged in the feces within the first 48 hrs. However, small amounts of
the drugs can be detected up to 11 days after oral administration in the urine and feces.
Ruminants, retain much of the benzimidazole in the rumen rather than passing it into the
abomasum. This increases the drug's retention time, increasing absorption into the blood
stream which in turn augments the antihelmintic activity (Hennessy and Prichard, 1981).
The remaining absorbed drug is excreted in the urine with only a small portion of the
drug excreted as the metabolites. The drug is metabolized by the liver via the
cytochrome P-4S0 system and microsomal flavin monooxygenases (Gottschall, 1990)
Residual quantities of the drugs have been detected in the liver up to 2 wks after
administration. Therefore, depending upon the formulation of the drug used, all
benzimidazoles require a minimum withdrawal time of 5-10 days; one needs to refer to
label instructions for withdrawal times in specific species (Roberson, 1988).
Anthelmintic activity of benzimidazoles is produced by interference of glucose
metabolism. Interference is accomplished in several ways, the main mode of action of the
benzimidazoles is to bind with the microtubule structural sub units, tubulin, which in
affects the microtubules, preventing further development of these structures. Without
the microtubules, the organism cannot carry on normal metabolic functions and the
organism dies The benzimidazoles attach selectively to the form of tubulin that
predominates in the parasites and is not found in the mammalian hosts Resistance to the
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drugs by the parasites is a function of selection for those parasites that can form tubulin
that has the same form as the host animals (Lacey, 1990; Mckellar, 1990).
Additionally, benzimidazoles have been shown to interfere with the fumarate
reductase which inhibits the generation of ATP in the mitochondria causing the parasite
to die due to a lack of usable energy (Roberson, 1988).
Toxicity of Benzimidazole Anthelmintics
Most of the members of this class of drugs, except albendazole, mebendazole and
thiabendazole, have a wide therapeutic index, and high doses of the drugs are well
tolerated by young, old, sick and debilitated animals. In humans, thiabendazole has been
shown to rarely cause anorexia, nausea, vomiting, dizziness, diarrhea and occasionally a
fever. Thiabendazole does have a hepatotoxic potential, therefore should be used with
caution in animals with liver disease. Mebendazole has been shown to be teratogenic
and embryotoxic in laboratory animals at a single dose. Dogs treated with mebendazole
at therapeutic levels occasionally develop acute hepatitis and jaundice Albendazole has
been shown to have a teratogenic effect in sheep, rabbits and rats; therefore, its use
during pregnancy is contraindicated Cattle have not shown any embryotoxic or
teratogenic effects as seen in other species that have been treated with albendazole,
however, poor conception rates have been reported in treated animals. It should also be
used with caution in patients with hepatic disease (Roberson, 1988).
Parbendazole and cambendazole exert a teratogenic effect In pregnant ewes
during the time of limb formation of the fetus, around day 20 of the pregnancy.
-
Therefore, they should not be used until after the 4th week of pregnancy of the ewe
(Roberson, 1988)
Fenbendazole as Anthelmintic
Fenbendazole is marketed in the United States by Hoechst-Roussel Agri Vet It
has several trade names including, Panacur®, Safe-Guard® and Axilur®. Panacur® is
the veterinarian-labeled drug and is marketed in the following formulations, 22%
granules for horses and dogs, 10% suspension for horses and cattle, a 10% paste for
horses and cattle
Safeguard® is the over-the-counter label of fenbendazole, marketed by Hoechst-
Roussel Agri Vet Co Safeguard® is marketed in the following forms, as a medicated
0.1% supplement block and medicated 20% protein block for cattle., as a free choice
medicated mineral mix and a 0.5% top dressing for cattle. It is in a \.8% granular
formulation for hogs. The dosage for cattle and horses is 5 mglkg of fenbendazole for
one treatment Dogs require a treatment of SO mglkg for three days.
FenbendazoJe in cattle is effective against the lung worm, Die/yoccm/u,\'
viviparus, the stomach worms, Haemonchus cantor/us, Ostertagia ostertagi, hiclw-
slrol1gyllls axel and the intestinal worms, Rlllwstomum phleholOmum, Nematodirlls
helve/ianlls, Cooperia punclara, C. oncophora, Trlchos/rongy/us axel, and Oesopha-




There are no anthelmintics approved for use in SAC's in the United States.
There are, however, many anthelmintics administered to these animals in an extra label
fashion based upon the veterinarians best clinical judgment.
TABLE I
ANTHELMfNTICS CURRENTLY ADMINISTERED AS
EXTRALABELDRUGSTOSOUTHAMffi~CAN
CAMELIDS (JOHNSON, 1994)
Fenbendazole Panacur® Hoechst-Roussel Agri vet
Ivermectin Ivomec® Merck Agri vet
Levamisole Tramasole® Merck Agri vet
Mebendazole Telmin® Pitman -Moore Inc.
Pyrantel pamoate Strongid® Pfizer Inc.
Thiabendazole Equizole® Merck Agri vet
Praziquantel Droncit® Haver-Lockhart Labs
Clorsuon Curatrem® Merck Agri vet
Internal parasites have been identified as a major health problem in the livestock
industry Although there are significant numbers of "minor species" animals raised in
this country for food, fiber and companion purposes, there is lack of legal (FDA-CVM
approved) drugs for use in these animals. There are over 100,000 llamas (Lama glama),
-
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and 10.000 alpacas with smaller numbers of guanacos and vicunas in the United States
by current estimates of the llama breeder association All members of the genus Lama
have the same number of chromosomes; therefore, the physiology of these animals will
be the same. Additionally the cash values of llamas range from $800.00 to $50,00000
and alpacas even higher (personal communication). In Oklahoma alone, there are 45
breeding farms that are members of the Oklahoma Llama Association, with numerous
others that are not registered with the association (Oklahoma Llama Association, 1998).
Although the incidence of intestinal parasitic diseases and their impact on the health of
SAC's in currently unknown, there is a significant need for identifying an anthelmintic
agent that is clinically effective and safe for use in these animals. Fenbendazole is a
member of the benzimidazole group of anthelmintics, and has broad spectrum of activity
against gastrointestinal helminths, lungworms, and some tapeworms (Roberson, 1988)
This drug is currently approved for and widely used in horses, dogs, pigs and
cattle. Although this drug has been studied extensively in sheep and goats, fenbendazole
is currently being recommended and used as an extra label anthelmintic in llamas, alpacas
and other SAC's (Fowler, 1998) However. there are no studies concerning the pharma-
cokinetics, efficacy and safety profJles of this drug in these animals.
In our preliminary clinical trials on fenbendazole (Safe-Guard®) at a dose of 5
mglkg in 59 llamas throughout the state of Oklahoma, we have found that the drug
produces a significant reduction in egg production of Trichostrongyloidea (Nematodil1ls
and Trichosrronglus) , and Trichuridoidea (Trichuris and Capillaria), by fecal egg count
(unpublished data). Therefore, the major objective of this study was to characterize oral
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CHAPTER II
ORAL PHARMACOKINETICS OF FENBENDAZOLE
IN LLAMAS, SOUTH AMERICAN CAMELIDS
Abstract
Llamas, South American Camelids are increasingly popular in the United States,
as a source of fiber, livestock guard, and pack animals. Internal parasites have been
identified as a major health problem in the livestock including llama industries. Currently,
there are no approved anthelmintics available for use in llamas. In this study, the
pharmacokinetics of a single, oral dose of fenbendazoJe paste at 5 rnglkg was evaluated
in llamas. Plasma fenbendazole concentration time profiles were best described by a
single companment model. After oral administration of fenbendazole, the tmax, and the
Cmax were 28.39 ± 12.80 h, and 0.27 ± 0 17 ~g/ml, respectively The t I12k. and tl/2 kel were
]6.25 ± 11 67 hand 36.00 ± 25.00 h, respectively. The apparent volume of distribution
(Vd) and the area under the curve (AUC) were] 1.28 ± 4.66 IIkg, and 22.52 ± 8.67
~g/ml, respectively, with a systemic clearance (Cis) of 0.26 ± 0 I 1 lIhJkg. The results of
this study indicate that fenbendazole when administered orally in the paste formulation,
was more rapidly absorbed in llamas compared to other ruminants including sheep, goats
and cattle as indicated by the short time taken to reach peak plasma concentrations




administration indicated a more complete absorption of the drug in this species compared
to other ruminants including cattle, sheep and goats. It was also found that the rate of
elimination of fenbendazole was prolonged in llamas as compared to sheep, goats, and
cattle. This may be partly due to slower hepatic metabolism of the drug. This was
consistent with the observation that fenbendazole when administered orally at a single
dose of 5 mglkg, was very effective clinically for a period of 4 wks, in llamas with
naturally occurring gastrointestinal parasitism (Beier, et aI., 1998).
lntroduction
1nternal parasites have been identified as a major heal! h problem in livestock
including llamas. Although there are significant numbers of "minor species" animals
raised in this country for food, fiber and companion purposes, there is Jack of legal
(FDA-CVM approved) drugs for use in these animals. The number of Llamas (Lama
glama) in North America is currently around 100,000 with approximately 10,000
Alpacas(Lama pacos), and smaller numbers of vicuna (Vicligna viclIK'la) and guanaco
(Lama gllC11l1coe) (personal communication). All members of the genus Llama have the
same number of chromosomes~ therefore, the physiology of these animals will be the
sam~. [n Oklahoma alone, there are 45 breeding farms that are members of the
Oklahoma Llama Breeders Association, with numerous others that are not registered
with the association (Oklahoma Llama Breeders Association, 1998). Although little is
known concerning the incidence of significant intestinal parasitic diseases and their
impact on the health of South American Camelids (SACs), there is a significant need for
identifying an anthelmintic agent that is clinically effective and safe for use in these
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animals, Fenbendazole is a member oftbe benzimidazole group of anthelmintics, and has
a broad spectrum of activlty against gastrointestinal parasites, lungworms. and some
tapeworms, This drug is currently approved and widely used in horses, dogs, pigs and
cattle (Roberson, 1988)
Fenbendazole has been studied extensively in sheep and goats, and is currently
being recommended and used as an extra label anthelmintic in llamas, alpacas and other
SAC's (Fowler, 1998; Cheney, 1989), However, there are no studies available
concerning the pharmacokinetic, clinical efficacy and safety profiles of this drug in these
animals, Therefore, the major objective of this study was to characterize oral
pharmacokinetic profiles of fenbendazole in llamas,
Materials and Methods
Animals
Five healthy, young adult llamas of both sexes purchased from local farms were
used in this study, Each animal's health was assessed by physical examination, CBC,
blood chemistry profiles, urinalysis, and fecal egg counts, The llamas were individually
housed at the University Lab Animal Resources' barn in accordance with the Guide for
the Care and Use of Laboratory Animals (NIH, 1985), Drinking water and a balanced
ration of grain and prairie hay were provided ad libitum,
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Experimental Procedure
Oral Administration of Fenbendazole and
Collection ofBlood Samples
A group of 5 llamas were used in this experiment Using chute restraint, aseptic
surgical technique and a local anesthetic, indwelling catheters were placed in the right
jugular vein of individual llamas. Twenty-four hours later, at time 0, fenbendazole (Safe
Guard™ [paste], Hoechst Roussel Agri Vet, Somerville, NJ) at a dose of 5 mg/kg was
orally administered to each animal using a dispensing gun (Hoechst Roussel Agri Vet,
Somerville, NJ). Five ml blood samples were collected in a heparinized syringe via the
indwelling intravenous catheter at 0, 15, 30, and 45 min and], 2, 3, 4, 6, 8, 10, 12, 18,
24, 36,48, 120 and 144 hr periods Following sample collection, 5 ml of normal saline
was injected to replace the volume of the blood sample collected. Blood samples were
centrifuged at 2000 X g for 10 minutes; plasma samples were collected and stored at -
200 e unlil analysis
Chemicals
All reagents used in this study were HPLC grade. Deionized distilled water
(Mil1i-Q water system, Millipore Corp., Bradford, MA) was used throughout the study
Analytical (HPLC) grade methanol, acetonitrile, chloroform, and ammonium phosphate
were obtained from Fisher Chemicals (Fair Lawn, NJ).
Standard Solutions.
Stock solutions of fenbendazole and its internal standard, oxibendazole (Sigma
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Chemical Co., St. Louis, MO), were prepared in methanol at concentrations of 0.25
mg/mJ and 0.1 mg/ml, respectively, and then stored at -20°C. The stock solutions were
diluted further to yield working solutions for the preparation of HPLC standards as
needed.
Extraction Procedure
For determination of fenbendazole, 10 (llglml) (I of oxibendazole) was added to
500 (lll of plasma) as the internal standard Seven ml of chloroform was then added, and
the mixture was vortexed thoroughly for 3 min. Following centrifugation (2000 X g, 5
min), the organic phase was transferred into a clean test tube after the aqueous layer was
frozen under acetone/dry ice conditions. The chloroform extracts were evaporated to
dryness under a slow steady stream of nitrogen. The resulting residue was reconstituted
in 100 (lll of methanol) and an aliquot of 50 (Ill of this solution) was injected into the
HPLC for analysis The extraction recovery of fenhendazole and oxybendazole from
llamas plasma in this study were 68.4 (3.31 %) and 68.4 (1.67%), respectively.
HPLC Determination of Plasma Fenbendazole
The HPLC analysis of plasma fenbendazole was carried out using the Waters
HPLC System (Waters, Millipore Co , Milford, MA). This unit was comprised of a pump
(Model 50 I), a tunable absorption detector (Waters 484) and chromatographic software
(Maxima 820). The analytical Lichrospher 100, RP-18 column (5 m, 250 x 4 mm)
(Hewlett Packard Inc.) and a guard column, Lichrospher 100, RP-18 (5 m, 4 x 4 mm)
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(Hewlett Packard Inc) were used to resolve fenbendazole and oxibendazole (internal
standard), respectively
The mobile phase acetonitrile: 10 mM ammonium phosphate buffer (pH 3 7,
4852, v/v) degassed, using a vacuum bottle and pump at -15 psi was used. The column
was equilibrated and eluted under isocratic conditions utilizing a flow rate of 1.0 ml/min
at ambient temperature. The detection wavelength was set at 292 nm. Peak width,
response time and slit were set a >003 min, 0.5 sand 8 nm, respectively. Standard
curves were prepared daily by comparing peak area ratios of fenbendazole concentra-
tions in plasma to peak area ratios of the internal standard
Method validation was performed by comparing peak area ratios of fenben-
dazole oxybendazole (internal standard) from a range of standard solutions in drug-free
llama plasma, Additionally, precision was determined by comparing the coefficients of
variation of inter-day variations in the peak area ratios of the standard curves. The
results of the variations indicated that the HPLC method was suitable for pharmaco-
kinetic studies of fenbendazole in llamas with an accuracy of 94 ± 8%, coefficient of
variation of ]0% and detection limit of quanti tat ion of 001 Ilglml.
Determination of the Pharmacokinetic Parameters
of Orally Administered Fenbendazole
Data fitting and pharmacokinetic parameter calculations were carried out by
estimation using the Boomer program (Bourne, el aI., 1984), and by analysis using the
PharmK program (Lu and Mao, J 993). An appropriate pharmacokinetic model was
chosen on the basis of lowest weighted squared residuals, lowest Akaike's information
criterion (AlC) value, R-squared, and correlation coefficient. The area under the curve
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(AVC) was calculated by the trapezoidal rule between 0 hr and the last sampling time
plus C/k, where C is the concentration of the last sampling and k is the elimination rate
constant (Gibaldi et aI., 1975) The systemic clearance (Cis) was determined by dividing
the dose by the AUC The time (tmax) taken to achieve peak concentration (Cm,,) was
calculated using differential calculus (Gibaldi et aI, 1975) The results are presented as
means and standard errors of the mean (SEM)
Results and Discussion
Several combinations of acetonitrile 10 mM ammonium phosphate buffer (pH
3 7) were evaluated as possible mobile phases. It was determined that a ratio of
acetonitrile 10 mM ammonium phosphate buffer (pH 3.7,48:52, v/v) was most suitable
for separation of fenbendazole. Changing the ratios of acetonitrile and ammonium
phosphate buffer alters the retention time of the fenbendazole. Larger areas yielded
shorter retention time, which caused interference by other peaks produced by the
methanol solvent.
Oral Pharmacokinetic Parameter~
The plasma fenbendazole concentration- time curves for oral route of administra-
tion is presented in (Fig. ]). The concentrations range of plasma was (0.025 - 0.283
~g/ml) after an oral dose of 5 mg/kg fenbendazole. The plasma concentration data for
fenbendazole after oral administration of 5 mg/kg was best fitted to the exponential
equation as shown below.
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The C is plasma fenbendazole concentration; Bf and B) represent mathematical
coefficients; and kef and ka represent the first order elimination and absorption rates
respectively Pharmacokinetic parameters of orally administrated fenbendazole are
presented in Table II.
TABLE II
PHARMACOKINETIC PARAMETERS FOLLOWING
ORAL ADMTNISTRATION OF FENBENDAZOLE
PASTE (5 mglkg) TO LLAMAS (n==5)
Parameter Value (Mean ± SEM)
1. K EL (HI) II. 0.025 ± 0.01
K. (hi) 0.070 ± 0.06
T 1/2b (h) 16.25 ± 11.67
T Iflkel (h) 36.000 ± 25.00
elB (I/h/kg) 0.260 ± 011
Vd (I/kg) ) 1280 ± 4.66
Cmax (I-!glml) 0.270 ± 0 17
Tmax (h) 28.390 ± 12.80
AUC (I-!g • hlml) 22520 ± 867
Abbreviations: K el - first order elimination rate constant;
K. - first order absorption rate constant; tl!2kJ is absorp-
tion half- life, K el is elimination half -life; Vd is apparent
volume of distribution calculated using AUC; ClB - is
body clearance of the drug.
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Following oral administration of fenbendazole in llamas, the drug reached peak
concentration of 0 27 ± 0 17 IJglml in the blood at approximately 10 hr and dropped to
a concentration below the detectable level at 140 hr (Figure 3)
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Figure 3. Mean Plasma Concentration Time Curves ofFenbendazole Paste in Llamas
(n=5) Following Oral Administration of A Single Dose at 5mglkg.
The peak plasma concentration (0.28 lJg/ml) of fenbendazole in llamas is
approximately two-thirds of the reponed value (040 uglml) for sheep (Lanusse cf aI.,
1995). However, it is twice the value of goats (0. J3 ~gJml) and cattle (0.1 5 ~glml)
(Short ef ai, 1987; Short et aI., 1987; Lanusse ef al., 1995). The time of 10 hr
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necessary to achieve peak plasma concentration in llamas was considerably less than that
of sheep (20 hr), goats (24 hr) and cattle (12 hr) (Short et aI., et aI., 1987; Short et aI,
1987~ Lanusse et aI., 1995) However, the elimination time (120 hr ± 025) is
significantly longer in llamas compared to those of sheep (70 hr), goats (73 hr) and cattle
(96 hr) (Short et aI., 1987, Short et aI., 1987; Sanyal et aI., 1993, Lanusse ef erl., 1995).
Conclusions
The results of this study indicate that fenbcndazole when administered orally in
the paste formulation, was more rapidly absorbed in llamas compared to other ruminants
including sheep, goats and cattle as indicated by the short time taken to reach peak
plasma concentrations. Higher peak plasma concentrations of fenbendazole in llamas
than those of goats or cattle indicated a more complete absorption of the drug in this
species However the absorption was less compared to sheep It was also found that the
rate of elimination of fenbendazole was prolonged in llamas compared to sheep, goats,
and cattle. This may be partly due to slower hepatic metabolism of the drug This was
consistent with the observation that fenbendazole when administered orally at a single
dose of 5 mg/kg, was very effective clinically for a period 4 wks, in llamas with naturally
occurring gastrointestinal parasitism (Beier et aI., 1999).
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CHAPTER In
CLINICAL EFFICACY PROFILES OF FENBENDAZOLE
IN LLAMAS. SOUTH AMERICAN CAMELIDS
Abstnct
Llamas (Lama glama) , South American Camelids (SAC's) are increasingly
popular in the United States, as a source of fiber, livestock guard and pack animals
Internal parasites have been identified as a major health problem in the livestock
including llama industries. Currently there are no approved anthelminrics available for
use in llamas In this study, fenbendazole was evaluated for clinical efficacy in control of
gastrointestinal parasitism in llamas.
Twelve healthy young adult of both male and female llamas naturally infested
with. Nemarodirus. trichostrongyles, trichuris, and Capillarw were divided into 2
groups. One group received a single oral dose of fenbendazole at 5 mglkg. The second
group received a comparable dose of water as a placebo. Fecal samples were obtained
per rectum from each animal prior to administration of either drug or placebo treatments
once a week for 4 wks. These samples were analyzed for total fecal egg burden using a
modified Wisconsin sugar floatation technique The fenbendazole treated group had a
reduced total fecal egg burden of 94%. 89%, 84% and 76%, respectively, for each
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week of the four week sampling period Nematodmis, trichostrongyles, and Trichuris all
had significant reduction in egg production for the entire period. However, egg
production by Cap;//aria was not significantly affected by the treatment. These results
confirm that fenbendazole is an effective anthelmintic in the treatment of naturally
occurring parasite infestations of NemalOdiru.'i, trichostrongyles, and Trichuris in llamas
gastrointestlna1system.
Introduction
Internal parasites are a major health problem in the livestock industry. Although
there are significant numbers of '·minor species" animals raised in this country for food,
fiber and companion purposes, there is Jack of legal (FDA-CVM approved) drugs for use
in these animals. The number of Llamas (Lama glama) in North America is currently
around 100,000 with approximately 10,000 AJpacas(Lama pacos). and smaller numbers
of vicuna(Vic//l,-.-na l'icugna) and guanaco (Lama guanicoe) (personal communication).
All members of the genus Lama have the same number of chromosomes, therefore. the
physiology of these animals will be the same. In Oklahoma alone there are 45 breeding
farms that are members of the Oklahoma Llama Association, with numerous others that
are not registered with the association (Oklahoma Llama Breeders Association, 1998).
Although little is known conceming the incidence of significant intestinal parasitic
diseases and their impact on the health of South American Camelids (SAC's), there is a
significant need for identifying an anthelmintic agent that is clinically effective and safe
for use in these animals. Fenbendazole is a member of the benzimidazole group of
anthelmintics, and has broad spectrum of activity against gastrointestinal parasites,
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lungworms, and some tapeworms. This drug is currently approved for and widely used in
horses, dogs, pigs and cattle (Roberson, ]988).
Fenbendazole has been studied extensively in sheep and goats, and is currently
being recommended and used as an extra label anthelmintic in llamas, alpacas and other
SAC's (Fowler, 1998; Cheney, 1989) However, there are no studies available
concerning the efficacy and safety profiles of this drug SAC's.
Fenbendazole (Safe Guard®), at a dose of 5 mg/kg, produces a reduction in egg
production of Nematodirus, Trichuris, Strongyloides, and Capillaria species, by fecal
egg count (Cheney, 1989). Therefore. the major objective of this study was to character-
ize clinical efficacy profiles of orally administered fenbendazoJe in naturally infested




Twelve fully vaccinated, healthy, llamas of varied ages of both sexes selected
from an Oklahoma farm, were used in this study. They had a significant number of
parasite eggs in their feces and were not treated for parasites during the 4 months prior
to this investigation. These animals were randomly assigned to 2 groups of 6 animals
each.
Animals in .this study were allowed to freely graze on 50 acres of native pasture
and supplemented with cracked corn and alfalfa hay once a day. They were allowed
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access to 3-sided sheds, permitting the animals to get oul of inclement weather. The
individual animal within a group was restrained with a halter and lead rope during
treatment and coli ecti on of fecal samples.
Experimental Method
Fenbendazole 10% paste (Safe Guard®, Hoechst-Roussel Agri-Vet. Sommer-
ville, NJ) was used in the study. A single dose of 5 mg/kg, to the nearest 220 Ib body
weight was administered orally to individual llamas within the treatment group. using a
cattle deworming gun (Hoechst-Roussel Agri-Vet, Sommerville, NJ). Individual animals
in the control group received a volume of water equal to the amount of the drug as a
placebo.
The llamas were monitored individually for any changes in appetite, posture,
attitude, respiration, activity, temperature, urination, and defecation, every 12 hrs for 4
wks following administration of either fenbendazole or water
Collection of Fecal Samples
A minimum of 3 g of feces were collected immediately prior to administration of
the drug and placebo from each animal in the study, and on every 7th day thereafter for
the next 4 wks. All fecal samples were obtained per rectum with a lubricated, gloved
hand. These samples were stored in labeled plastic bags and refrigerated at 5°C until
ful1her analysis.
35
Delermi alion OrTOlal Fecal E Burden
The numbers of eggs per gram of feces were determined uSing a modified
Wisconsin sugar flotation technique (Jordan et 01., 1986) Three grams of feces were
placed into a clean beaker with 60 ml of water, and stirred until the feces were in a
homogeneous suspension. The suspension was strained through wire gauze into a clean
150-ml glass beaker, to remove large plant fibers. An additional 60 ml of water was
added to the beaker, stirred then poured over the plant material on the wire gauze, while
the plant fibers were stirred with a wooden applicator The filtrate was allocated into a
15 ml centrifuge tube, which was placed into a clinical centrifuge and spun at 2000 X G
for 10 min The water was decanted off of the pellet of material at the bottom of the
tube and discarded A super-saturated solution of sugar was added to the centrifuge
tube, and the pellet of fecal material was resuspended. Additional amount of sugar water
was added to form a meniscus on the tube and covered with a 25-mm square glass cover
slip. The tube was returned to the centrifuged. The cover slip was placed on a labeled
clean glass microscope slide. A second glass cover slip was placed on the top of the
centrifuge tube and centrifuged. This cover slip was placed next to the previous cover
slip. The parasite eggs belonging to specific groups (trichostrongyles, Trichuris, and
Capillaria) of gastrointestinal nematodes, were identified microscopically The total
number of eggs per gram was then calculated using the following formulas~
3 gm feces 1120 ml dH20 = 0.025 gm/mJ
0.025 gm/ml x 15 ml = 0.375 gm/l 5 ml
I ml/0.375 gm = 2.67 factor for eggs/gm offeces
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Number of eggs counted on each slide x 2.67 factor = eggs/gm of feces. (Jordan
et aI., 1986) The total egg burden with the mean ±SE of the mean was calculated for
individual llamas within both the placebo and treatment groups
Statistical Analysis of the Data,
The means ±SE of the mean of the total fecal egg burden of both placebo and
fenbendazoJe treated groups were subjected to analysis for significance is using the SPSS
program ( SPSS Inc.) Due to the size of the sample number, the Mann-Whitney one
tailed test, was used to determine the significance of the difference between the two
groups A one tailed Mann-Whitney was employed to determine the significance of the
means within the treatment group A value of P < 0.05 was considered to be significant
(Shott, 1990)
Results and Discussion
Oral administration of fenbendazole, at a single dose of 5 mg/kg body weight,
failed to produce any adverse effects including changes in appetite, posture, attitude,
respiration, activity, temperature, urination, and defecation, for the duration of the
experiment These findings are consistent with the long history of safe use of fen ben-
dazole and other benzimidazole analogues in other domestic ruminant species (Kennedy,
1975; Anderson, 1977; Gregory, 1985). Microscopic examination of the visual
appearance of eggs present in the fecal material of both placebo and fenbendazole treated
groups confirmed the rresence of trichostrongyles, Trichuris, and Capillaria in the
gastrointestinal system of the llamas These findings are in total agreement with those of
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the previous studies in llamas (Cheney, 1989; Fowler, 1998). Additionally, these groups
of internal parasites have been a commonly associated with gastrointestinal parasitism in
domestic ruminants of North American Continent (Kennedy, 1975; Anderson, 1977).
The total fecal egg burden of all the four groups of parasites including
trichostronglyes, Trichuris, and Capillaria in both treatment and placebo groups were
54.2 ±SE and 37 ±SE, respectively, prior to either fenbendazole or placebo treatment.
Oral administration of a single dose offenbendazole at 5 rnglkg body weight, produced a
reduction in total fecal egg burden of all 4 groups of gastrointestinal parasites for a
period of 4 wks observed (Figure 4). Concurrently, placebo administration failed to


















Figure 4. Mean Combined Fecal Egg Counts of Trichostron-
gyles in Nematodirus, Trichuris, and Capillaria in
Llamas Over 4 Weeks Following Oral Administra-
tion of Placebo (0=6) and Fenbendazole Paste
(n=6, in a Single Dose of 5mglkg)
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Based upon the analysis of fecal egg burden of individual parasites. Trichuris (p
> 0004), Nematodims (p > 0,075) and Tricas'rongy/s (p > 0008), fenbendazole has a
significant effect upon reducing the numbers of eggs produced by these parasites
(Figures 5 A,B,C). The number of Capillaria eggs was not reduced significantly by the
administration of fenbendazole (Figure 5 D).
It appears that the drug did not affect this species of parasite. Perhaps this might
be due to the fact that the Capillaria species in addition to being found in the
gastrointestinal tract can also be found in the lungs, liver and kidneys Eggs produced by
these parasites in the lungs arc expelled into the throat in mucus, swallowed and excreted
in the feces (Bowman, 1995)
The results of this study compare favorably with nllmerous other studies of
fenbendazole on domestic ruminant species (Kennedy, 1975; Anderson, 1977).
Various methods including fecal eggs counts, larval culture. pasture larval
counts, necropsy evaluation, and clinical trials, have been used to determine the clinical
efficacy of an anthelmintic in domestic animals (Uhlinger, 1996~ Searson, 1977,
Anderson, 1977; Sutherland, 1997).
Conclusions
Using fecal egg counts, this study was the first attempt to characterize the clinical
efficacy of fenbendazole in llamas. The results of this study demonstrate that fenben-
dazole is effective in significantly reducing the total fecal egg burden of Trichur/.\· and
trichostrongyles in llamas. With cash values of llamas ranging from $800.00 to
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efficacious anthelmintic such as fenbendazole will Improve the health as well as the
profitability of these animals.
More extensive studies including, larval culture and necropsy evaluation have to
be condcted to further characterize fenbendazole as a safe and effective anthelmintic for
llamas and other SAC's.
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CHAPTER IV
SUMMARY AND CONCLUSIONS
Internal parasites are a major health problem in the livestock industry Although
there are significant numbers of "minor species" animals raised in this country for food,
fiber and companion purposes, there is lack of legal (FDA-CVM approved) drugs for use
in these animals. The number of Llamas (Lama glama) in North America is currently
around 100,000 with approximately 10,000 Alpacas (Lama pacos), and smaller numbers
of vicuna (Viclfgna viclfgl1a) and guanaco (Lama guanicoe) (personal communication).
Little is known concerning the incidence of significant intestinal parasitic diseases and
their impact on the health of South American Camelids SAC's, there is a significant need
for identifying an anthelmintic agent that is clinically effective and safe for use in these
animals
Fenbendazole, a member of the benzimidazole group of anthelmintics, has broad
spectrum of activity against gastrointestinal parasites, lungworms, and some tapeworms
This drug is currently approved for and widely used in horses, dogs, pigs and cattle and
recommended in llamas. However, there are no studies available concerning the efficacy
and safety profiles of this drug SACs. In this study, oral pharmacokinetics and clinical
efficacy profiles offenbendazole were evaluated in llamas.
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In the pharmacokinetic study, five healthy, young adult, male and female llamas
catheterized and administered of a single oral dose of 5 mglkg fenbendazole, 5 ml blood
samples were drawn at time; 0, IS, 30, 45 min and 1, 2, 4, 6, 8, 10, 12, 24, 36, 48, 120
and 144 hrs. The plasma samples were then analyzed by HPLC for concentration of
fenbendazol e.
Fenbendazole enters the blood stream of llamas and reaches peak concentration of
0.28 ~g1ml ± 0 l29 in 10 hrs and is eliminated by 120 hrs. This peak level in plasma is
comparable with those of other ruminants. The elimination rate is slower than that of
sheep, cattle or goats
In the clinical efficacy study, 12 healthy, young adults of both male and female
llamas naturally infested with trichostrongyles in Nematodirus, Trichuris and Copillorw
were divided into 2 groups. One group received a single oral dose of fenbendazole at 5
mg/kg The second group received a comparable dose of water as a placebo. The
fenbendazole treated group had a reduced total fecal egg burden of 95%, 89%, 84% and
76%, respectively, for one through four wk sampling period. Nematodmls, trichostron-
gyles, and Trichuris all had significant reduction in fecal egg counts for the entire period.
However, egg production by Capillaria was not significantly affected by the treatment
These results, confirm that, fenbendazole is an effective anthelmintic in the treatment of
naturally occurring nematode infestations
Fenbendazole appears to be a drug that IS safe and effective against susceptible
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